Atrial natriuretic peptide in Cushing's disease

Area of Science:

• Endocrinology
• Cardiovascular Physiology
• Hormone Secretion

Background:

• Atrial Natriuretic Peptide (ANF) is secreted by atrial myocytes in response to stretch, with elevated levels observed in fluid-retaining states.
• Dexamethasone enhances ANF secretion via gene expression and mRNA synthesis.
• High ANF levels occur in normal individuals after cortisol and ACTH administration, but data in Cushing's disease are limited.

Purpose of the Study:

• To investigate basal ANF levels and its response to postural changes and volume expansion in patients with Cushing's disease.
• To clarify the relationship between glucocorticoid excess and ANF secretion.

Main Methods:

• Measurement of basal ANF values in eight patients with Cushing's disease.
• Assessment of ANF response to postural changes (supine vs. upright).
• Evaluation of ANF response to volume expansion (sodium load).

Main Results:

• Patients with Cushing's disease showed higher basal ANF values compared to normal individuals.
• ANF levels significantly increased after volume expansion (47.8 +/- 5.1 pg/ml pre-load to 69.9 +/- 7.0 pg/ml post-load).
• ANF levels changed minimally with postural maneuvers (47.3 +/- 3.2 pg/ml supine vs. 41.7 +/- 5.1 pg/ml upright).

Conclusions:

• ANF secretion is enhanced in Cushing's disease.
• The regulation of ANF secretion appears partially altered in Cushing's disease.
• A direct relationship between elevated ANF and glucocorticoid excess is suggested, independent of demonstrated hypervolemia.